Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users

Clinical trial NCT04995029 · COMPLETED

Trial details

NCT number: NCT04995029
Sponsor: Indivior Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Moderate to Severe Opioid-use Disorder

Start date: 2021-10-26
Primary completion: 2024-06-26
Enrollment: 785

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.